Association of TNF2, a TNF-α Promoter Polymorphism, With Septic Shock Susceptibility and Mortality
- 11 August 1999
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 282 (6), 561-568
- https://doi.org/10.1001/jama.282.6.561
Abstract
Research from JAMA — Association of TNF2, a TNF-α Promoter Polymorphism, With Septic Shock Susceptibility and Mortality — A Multicenter Study — ContextTumor necrosis factor alpha (TNF-α) is believed to be a cytokine central to pathogenesis of septic shock. TNF2, a polymorphism within the TNF-α gene promoter, has been associated with enhanced TNF-α production and negative outcome in some severe infections.ObjectivesTo investigate the frequency of the TNF2 allele in patients with septic shock and to determine whether the allele is associated with the occurrence and outcome of septic shock.DesignMulticenter case-control study conducted from March 1996 to June 1997.SettingSeven medical intensive care units in university hospitals.SubjectsEighty-nine patients with septic shock and 87 healthy unrelated blood donors.Main Outcome MeasuresFrequency of the TNF2 allele among patients with septic shock and among those who died and the level of corresponding TNF-α concentrations.ResultsMortality among patients with septic shock was 54%, consistent with the predicted mortality from the Simplified Acute Physiologic Score (SAPS II) value. The polymorphism frequencies of the controls and the patients with septic shock differed only at the TNF2 allele (39% vs 18% in the septic shock and control groups, respectively, P=.002). Among the septic shock patients, TNF2 polymorphism frequency was significantly greater among those who had died (52% vs 24% in the survival group, P=.008). Concentrations of TNF-α were higher in 68% and 52% with the TNF2 and TNF1 polymorphisms, respectively, but their median values (48 pg/mL vs 29 pg/mL) were not statistically different (P = .31). After controlling for age and the probability of death, derived by the SAPS II score, multiple logistic regression analysis showed that, for the same rank of SAPS II value, patients with the TNF2 allele had a 3.7-fold risk of death (95% confidence interval, 1.37-10.24).ConclusionThe TNF2 allele is strongly associated with susceptibility to septic shock and death due to septic shock.Keywords
This publication has 24 references indexed in Scilit:
- Treating Patients with Severe SepsisNew England Journal of Medicine, 1999
- Proinflammatory and Anti-inflammatory Cytokines as Mediators in the Pathogenesis of Septic ShockChest, 1997
- The −308 tumor necrosis factor-α promoter polymorphism effects transcriptionMolecular Immunology, 1997
- Current Understanding of SepsisClinical Infectious Diseases, 1996
- Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study GroupPublished by American Medical Association (AMA) ,1995
- Adjunctive Therapy for Septic Shock: A Review of Experimental ApproachesClinical Infectious Diseases, 1995
- Endotoxin‐Stimulated Human Monocyte Secretion of Interleukin 1, Tumour Necrosis Factor Alpha, and Prostaglandin E2 Shows Stable Interindividual DifferencesScandinavian Journal of Immunology, 1988
- Detection of Circulating Tumor Necrosis Factor after Endotoxin AdministrationNew England Journal of Medicine, 1988
- Shock and Tissue Injury Induced by Recombinant Human CachectinScience, 1986
- Nearly all single base substitutions in DNA fragments joined to a GC-clamp can be detected by denaturing gradient gel electrophoresisNucleic Acids Research, 1985